Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Oz Show, CNN, Wired, Good Morning America, the New York Times, Fast Company, Bloomberg, and a slew of other major media publications
A 2016 study in Journal of Physiology and Pharmacology demonstrated BPC-157 could counteract certain dopamine-related behaviors in animal models, suggesting potential applications in neurological conditions
BPC-157 is an investigational synthetic peptide that has not been approved by the FDA for any use
Plasma stability and protein binding Plasma stability studies on BPC-157 have suggested it is notably resistant to rapid proteolytic degradation in serum a feature that may contribute to the observed effect durability
not for human consumption
%20-%202026-02-12T083130.527.jpg?w=1200&max-h=1200&fit=crop&auto=format)
